Healthcare -
Biotechnology - NASDAQ - NL
$ 15.6
-1.89 %
$ 843 M
Market Cap
-5.71
P/E
PHVS - COST OF REVENUE
Cost of Revenue PHVS - Pharvaris N.V.
252 K
LAST VALUE
77.07%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR